APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pain Management Drugs & Devices

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pain Management Drugs & Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025196 pages

Choose your research edition.

Industry ResearchPain Management Drugs & Devices Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Pain Management Drugs & Devices Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Pain Management Drugs & Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pain Management Drugs & Devices Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Pain Management Drugs & Devices Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Pain Management Drugs & Devices market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pain Management Drugs & Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pain Management Drugs & Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pain Management Drugs & Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pain Management Drugs & Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pain Management Drugs & Devices include Abbott, Johnson & Johnson, Medtronic Inc., Eli Lilly & Co., Pfizer, Abbvie Inc., Purdue Pharmaceuticals Lp, Novartis International Ag and Hisamitsu Pharmaceutical Co. Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pain Management Drugs & Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pain Management Drugs & Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pain Management Drugs & Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pain Management Drugs & Devices market size, projected growth trends, production technologies, key applications, and end-use industries.

Pain Management Drugs & Devices Segment by Company

Abbott

Johnson & Johnson

Medtronic Inc.

Eli Lilly & Co.

Pfizer

Abbvie Inc.

Purdue Pharmaceuticals Lp

Novartis International Ag

Hisamitsu Pharmaceutical Co. Inc.

Glaxosmithkline

Endo International

Djo Global Inc.

Astrazeneca Depomed Inc.

Pain Management Drugs & Devices Segment by Type

Pharmaceuticals

Devices

Pain Management Drugs & Devices Segment by Application

Cancer Pain

Obstetrical Pain

Musculoskeletal Pain

Migraine Headache Pain

Burn Pain

Neuropathic Pain

Dental/Facial Pain

Pain Management Drugs & Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pain Management Drugs & Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pain Management Drugs & Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pain Management Drugs & Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pain Management Drugs & Devices market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pain Management Drugs & Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pain Management Drugs & Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pain Management Drugs & Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pain Management Drugs & Devices Industry Trends Table 2. Pain Management Drugs & Devices Industry Drivers Table 3. Pain Management Drugs & Devices Industry Opportunities and Challenges Table 4. Pain Management Drugs & Devices Industry Restraints Table 5. Global Pain Management Drugs & Devices Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pain Management Drugs & Devices Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pain Management Drugs & Devices Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Pain Management Drugs & Devices Sales Market Share by Manufacturers Table 9. Global Pain Management Drugs & Devices Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Pain Management Drugs & Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pain Management Drugs & Devices Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pain Management Drugs & Devices Manufacturers, Product Type & Application Table 13. Global Pain Management Drugs & Devices Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pain Management Drugs & Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Pharmaceuticals Table 17. Major Manufacturers of Devices Table 18. Global Pain Management Drugs & Devices Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 19. Global Pain Management Drugs & Devices Sales by Type (2021-2026) & (W Units) Table 20. Global Pain Management Drugs & Devices Sales by Type (2027-2032) & (W Units) Table 21. Global Pain Management Drugs & Devices Sales Market Share by Type (2021-2026) Table 22. Global Pain Management Drugs & Devices Sales Market Share by Type (2027-2032) Table 23. Global Pain Management Drugs & Devices Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 24. Global Pain Management Drugs & Devices Revenue by Type (2021-2026) & (W Units) Table 25. Global Pain Management Drugs & Devices Revenue by Type (2027-2032) & (W Units) Table 26. Global Pain Management Drugs & Devices Revenue Market Share by Type (2021-2026) Table 27. Global Pain Management Drugs & Devices Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Cancer Pain Table 29. Major Manufacturers of Obstetrical Pain Table 30. Major Manufacturers of Musculoskeletal Pain Table 31. Major Manufacturers of Migraine Headache Pain Table 32. Major Manufacturers of Burn Pain Table 33. Major Manufacturers of Neuropathic Pain Table 34. Major Manufacturers of Dental/Facial Pain Table 35. Global Pain Management Drugs & Devices Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 36. Global Pain Management Drugs & Devices Sales by Application (2021-2026) & (W Units) Table 37. Global Pain Management Drugs & Devices Sales by Application (2027-2032) & (W Units) Table 38. Global Pain Management Drugs & Devices Sales Market Share by Application (2021-2026) Table 39. Global Pain Management Drugs & Devices Sales Market Share by Application (2027-2032) Table 40. Global Pain Management Drugs & Devices Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 41. Global Pain Management Drugs & Devices Revenue by Application (2021-2026) & (W Units) Table 42. Global Pain Management Drugs & Devices Revenue by Application (2027-2032) & (W Units) Table 43. Global Pain Management Drugs & Devices Revenue Market Share by Application (2021-2026) Table 44. Global Pain Management Drugs & Devices Revenue Market Share by Application (2027-2032) Table 45. Global Pain Management Drugs & Devices Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 46. Global Pain Management Drugs & Devices Sales by Region (2021-2026) & (W Units) Table 47. Global Pain Management Drugs & Devices Sales Market Share by Region (2021-2026) Table 48. Global Pain Management Drugs & Devices Sales Forecasted by Region (2027-2032) & (W Units) Table 49. Global Pain Management Drugs & Devices Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Pain Management Drugs & Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 51. North America Pain Management Drugs & Devices Sales by Country (2021-2026) & (W Units) Table 52. North America Pain Management Drugs & Devices Sales by Country (2027-2032) & (W Units) Table 53. Europe Pain Management Drugs & Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 54. Europe Pain Management Drugs & Devices Sales by Country (2021-2026) & (W Units) Table 55. Europe Pain Management Drugs & Devices Sales by Country (2027-2032) & (W Units) Table 56. Asia Pacific Pain Management Drugs & Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 57. Asia Pacific Pain Management Drugs & Devices Sales by Country (2021-2026) & (W Units) Table 58. Asia Pacific Pain Management Drugs & Devices Sales by Country (2027-2032) & (W Units) Table 59. South America, Middle East and Africa Pain Management Drugs & Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 60. South America, Middle East and Africa Pain Management Drugs & Devices Sales by Country (2021-2026) & (W Units) Table 61. South America, Middle East and Africa Pain Management Drugs & Devices Sales by Country (2027-2032) & (W Units) Table 62. Global Pain Management Drugs & Devices Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Pain Management Drugs & Devices Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Pain Management Drugs & Devices Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Pain Management Drugs & Devices Revenue Market Share by Region (2021-2026) Table 66. Global Pain Management Drugs & Devices Revenue Market Share by Region (2027-2032) Table 67. Abbott Company Information Table 68. Abbott Business Overview Table 69. Abbott Pain Management Drugs & Devices Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Abbott Pain Management Drugs & Devices Product Portfolio Table 71. Abbott Recent Development Table 72. Johnson & Johnson Company Information Table 73. Johnson & Johnson Business Overview Table 74. Johnson & Johnson Pain Management Drugs & Devices Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Johnson & Johnson Pain Management Drugs & Devices Product Portfolio Table 76. Johnson & Johnson Recent Development Table 77. Medtronic Inc. Company Information Table 78. Medtronic Inc. Business Overview Table 79. Medtronic Inc. Pain Management Drugs & Devices Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Medtronic Inc. Pain Management Drugs & Devices Product Portfolio Table 81. Medtronic Inc. Recent Development Table 82. Eli Lilly & Co. Company Information Table 83. Eli Lilly & Co. Business Overview Table 84. Eli Lilly & Co. Pain Management Drugs & Devices Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Eli Lilly & Co. Pain Management Drugs & Devices Product Portfolio Table 86. Eli Lilly & Co. Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer Pain Management Drugs & Devices Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Pfizer Pain Management Drugs & Devices Product Portfolio Table 91. Pfizer Recent Development Table 92. Abbvie Inc. Company Information Table 93. Abbvie Inc. Business Overview Table 94. Abbvie Inc. Pain Management Drugs & Devices Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Abbvie Inc. Pain Management Drugs & Devices Product Portfolio Table 96. Abbvie Inc. Recent Development Table 97. Purdue Pharmaceuticals Lp Company Information Table 98. Purdue Pharmaceuticals Lp Business Overview Table 99. Purdue Pharmaceuticals Lp Pain Management Drugs & Devices Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Purdue Pharmaceuticals Lp Pain Management Drugs & Devices Product Portfolio Table 101. Purdue Pharmaceuticals Lp Recent Development Table 102. Novartis International Ag Company Information Table 103. Novartis International Ag Business Overview Table 104. Novartis International Ag Pain Management Drugs & Devices Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Novartis International Ag Pain Management Drugs & Devices Product Portfolio Table 106. Novartis International Ag Recent Development Table 107. Hisamitsu Pharmaceutical Co. Inc. Company Information Table 108. Hisamitsu Pharmaceutical Co. Inc. Business Overview Table 109. Hisamitsu Pharmaceutical Co. Inc. Pain Management Drugs & Devices Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Hisamitsu Pharmaceutical Co. Inc. Pain Management Drugs & Devices Product Portfolio Table 111. Hisamitsu Pharmaceutical Co. Inc. Recent Development Table 112. Glaxosmithkline Company Information Table 113. Glaxosmithkline Business Overview Table 114. Glaxosmithkline Pain Management Drugs & Devices Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Glaxosmithkline Pain Management Drugs & Devices Product Portfolio Table 116. Glaxosmithkline Recent Development Table 117. Endo International Company Information Table 118. Endo International Business Overview Table 119. Endo International Pain Management Drugs & Devices Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Endo International Pain Management Drugs & Devices Product Portfolio Table 121. Endo International Recent Development Table 122. Djo Global Inc. Company Information Table 123. Djo Global Inc. Business Overview Table 124. Djo Global Inc. Pain Management Drugs & Devices Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Djo Global Inc. Pain Management Drugs & Devices Product Portfolio Table 126. Djo Global Inc. Recent Development Table 127. Astrazeneca Depomed Inc. Company Information Table 128. Astrazeneca Depomed Inc. Business Overview Table 129. Astrazeneca Depomed Inc. Pain Management Drugs & Devices Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Astrazeneca Depomed Inc. Pain Management Drugs & Devices Product Portfolio Table 131. Astrazeneca Depomed Inc. Recent Development Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Pain Management Drugs & Devices Distributors List Table 135. Pain Management Drugs & Devices Customers List Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Pain Management Drugs & Devices Product Image Figure 2. Global Pain Management Drugs & Devices Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pain Management Drugs & Devices Market Size (2021-2032) & (US$ Million) Figure 4. Global Pain Management Drugs & Devices Sales (2021-2032) & (W Units) Figure 5. Global Pain Management Drugs & Devices Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pain Management Drugs & Devices Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Pharmaceuticals Image Figure 9. Devices Image Figure 10. Global Pain Management Drugs & Devices Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 11. Global Pain Management Drugs & Devices Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Pain Management Drugs & Devices Sales Market Share by Type (2021-2032) Figure 13. Global Pain Management Drugs & Devices Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Pain Management Drugs & Devices Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Pain Management Drugs & Devices Revenue Market Share by Type (2021-2032) Figure 16. Cancer Pain Image Figure 17. Obstetrical Pain Image Figure 18. Musculoskeletal Pain Image Figure 19. Migraine Headache Pain Image Figure 20. Burn Pain Image Figure 21. Neuropathic Pain Image Figure 22. Dental/Facial Pain Image Figure 23. Global Pain Management Drugs & Devices Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 24. Global Pain Management Drugs & Devices Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Pain Management Drugs & Devices Sales Market Share by Application (2021-2032) Figure 26. Global Pain Management Drugs & Devices Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 27. Global Pain Management Drugs & Devices Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Pain Management Drugs & Devices Revenue Market Share by Application (2021-2032) Figure 29. North America Pain Management Drugs & Devices Sales and Growth Rate (2021-2032) & (W Units) Figure 30. North America Pain Management Drugs & Devices Sales Market Share by Country (2021-2032) Figure 31. U.S. Pain Management Drugs & Devices Sales and Growth Rate (2021-2032) & (W Units) Figure 32. Canada Pain Management Drugs & Devices Sales and Growth Rate (2021-2032) & (W Units) Figure 33. Mexico Pain Management Drugs & Devices Sales and Growth Rate (2021-2032) & (W Units) Figure 34. Europe Pain Management Drugs & Devices Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Europe Pain Management Drugs & Devices Sales Market Share by Country (2021-2032) Figure 36. Germany Pain Management Drugs & Devices Sales and Growth Rate (2021-2032) & (W Units) Figure 37. France Pain Management Drugs & Devices Sales and Growth Rate (2021-2032) & (W Units) Figure 38. U.K. Pain Management Drugs & Devices Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Italy Pain Management Drugs & Devices Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Netherlands Pain Management Drugs & Devices Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Asia Pacific Pain Management Drugs & Devices Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Asia Pacific Pain Management Drugs & Devices Sales Market Share by Country (2021-2032) Figure 43. China Pain Management Drugs & Devices Sales and Growth Rate (2021-2032) & (W Units) Figure 44. Japan Pain Management Drugs & Devices Sales and Growth Rate (2021-2032) & (W Units) Figure 45. South Korea Pain Management Drugs & Devices Sales and Growth Rate (2021-2032) & (W Units) Figure 46. Southeast Asia Pain Management Drugs & Devices Sales and Growth Rate (2021-2032) & (W Units) Figure 47. India Pain Management Drugs & Devices Sales and Growth Rate (2021-2032) & (W Units) Figure 48. Australia Pain Management Drugs & Devices Sales and Growth Rate (2021-2032) & (W Units) Figure 49. South America, Middle East and Africa Pain Management Drugs & Devices Sales and Growth Rate (2021-2032) & (W Units) Figure 50. South America, Middle East and Africa Pain Management Drugs & Devices Sales Market Share by Country (2021-2032) Figure 51. Brazil Pain Management Drugs & Devices Sales and Growth Rate (2021-2032) & (W Units) Figure 52. South Africa Pain Management Drugs & Devices Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Saudi Arabia Pain Management Drugs & Devices Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Turkey Pain Management Drugs & Devices Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Argentina Pain Management Drugs & Devices Sales and Growth Rate (2021-2032) & (W Units) Figure 56. UAE Pain Management Drugs & Devices Sales and Growth Rate (2021-2032) & (W Units) Figure 57. Egypt Pain Management Drugs & Devices Sales and Growth Rate (2021-2032) & (W Units) Figure 58. Chile Pain Management Drugs & Devices Sales and Growth Rate (2021-2032) & (W Units) Figure 59. Global Pain Management Drugs & Devices Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Pain Management Drugs & Devices Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Figure 62. North America Pain Management Drugs & Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Figure 64. Europe Pain Management Drugs & Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Pain Management Drugs & Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Pain Management Drugs & Devices Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Pain Management Drugs & Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Pain Management Drugs & Devices Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Pain Management Drugs & Devices Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Pharmaceuticals
  • Devices
Applications
  • Cancer Pain
  • Obstetrical Pain
  • Musculoskeletal Pain
  • Migraine Headache Pain
  • Burn Pain
  • Neuropathic Pain
  • Dental/Facial Pain
Companies covered
  • Abbott
  • Johnson & Johnson
  • Medtronic Inc.
  • Eli Lilly & Co.
  • Pfizer
  • Abbvie Inc.
  • Purdue Pharmaceuticals Lp
  • Novartis International Ag
  • Hisamitsu Pharmaceutical Co. Inc.
  • Glaxosmithkline
  • Endo International
  • Djo Global Inc.
  • Astrazeneca Depomed Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pain Management Drugs & Devices Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pain Management Drugs & Devices Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pain Management Drugs & Devices Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pain Management Drugs & Devices Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pain Management Drugs & Devices Market Dynamics
  1. 2.1 Pain Management Drugs & Devices Industry Trends
  2. 2.2 Pain Management Drugs & Devices Industry Drivers
  3. 2.3 Pain Management Drugs & Devices Industry Opportunities and Challenges
  4. 2.4 Pain Management Drugs & Devices Industry Restraints
3 Pain Management Drugs & Devices Market by Manufacturers
  1. 3.1 Global Pain Management Drugs & Devices Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pain Management Drugs & Devices Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pain Management Drugs & Devices Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pain Management Drugs & Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pain Management Drugs & Devices Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pain Management Drugs & Devices Manufacturers, Product Type & Application
  7. 3.7 Global Pain Management Drugs & Devices Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pain Management Drugs & Devices Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pain Management Drugs & Devices Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pain Management Drugs & Devices Tier 1, Tier 2, and Tier 3
4 Pain Management Drugs & Devices Market by Type
  1. 4.1 Pain Management Drugs & Devices Type Introduction
  2. 4.1.1 Pharmaceuticals
  3. 4.1.2 Devices
  4. 4.2 Global Pain Management Drugs & Devices Sales by Type
  5. 4.2.1 Global Pain Management Drugs & Devices Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pain Management Drugs & Devices Sales by Type (2021-2032)
  7. 4.2.3 Global Pain Management Drugs & Devices Sales Market Share by Type (2021-2032)
  8. 4.3 Global Pain Management Drugs & Devices Revenue by Type
  9. 4.3.1 Global Pain Management Drugs & Devices Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pain Management Drugs & Devices Revenue by Type (2021-2032)
  11. 4.3.3 Global Pain Management Drugs & Devices Revenue Market Share by Type (2021-2032)
5 Pain Management Drugs & Devices Market by Application
  1. 5.1 Pain Management Drugs & Devices Application Introduction
  2. 5.1.1 Cancer Pain
  3. 5.1.2 Obstetrical Pain
  4. 5.1.3 Musculoskeletal Pain
  5. 5.1.4 Migraine Headache Pain
  6. 5.1.5 Burn Pain
  7. 5.1.6 Neuropathic Pain
  8. 5.1.7 Dental/Facial Pain
  9. 5.2 Global Pain Management Drugs & Devices Sales by Application
  10. 5.2.1 Global Pain Management Drugs & Devices Sales by Application (2021 VS 2025 VS 2032)
  11. 5.2.2 Global Pain Management Drugs & Devices Sales by Application (2021-2032)
  12. 5.2.3 Global Pain Management Drugs & Devices Sales Market Share by Application (2021-2032)
  13. 5.3 Global Pain Management Drugs & Devices Revenue by Application
  14. 5.3.1 Global Pain Management Drugs & Devices Revenue by Application (2021 VS 2025 VS 2032)
  15. 5.3.2 Global Pain Management Drugs & Devices Revenue by Application (2021-2032)
  16. 5.3.3 Global Pain Management Drugs & Devices Revenue Market Share by Application (2021-2032)
6 Global Pain Management Drugs & Devices Sales by Region
  1. 6.1 Global Pain Management Drugs & Devices Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pain Management Drugs & Devices Sales by Region (2021-2032)
  3. 6.2.1 Global Pain Management Drugs & Devices Sales by Region (2021-2026)
  4. 6.2.2 Global Pain Management Drugs & Devices Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pain Management Drugs & Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pain Management Drugs & Devices Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pain Management Drugs & Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pain Management Drugs & Devices Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pain Management Drugs & Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pain Management Drugs & Devices Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pain Management Drugs & Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pain Management Drugs & Devices Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pain Management Drugs & Devices Revenue by Region
  1. 7.1 Global Pain Management Drugs & Devices Revenue by Region
  2. 7.1.1 Global Pain Management Drugs & Devices Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pain Management Drugs & Devices Revenue by Region (2021-2026)
  4. 7.1.3 Global Pain Management Drugs & Devices Revenue by Region (2027-2032)
  5. 7.1.4 Global Pain Management Drugs & Devices Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pain Management Drugs & Devices Revenue (2021-2032)
  8. 7.2.2 North America Pain Management Drugs & Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pain Management Drugs & Devices Revenue (2021-2032)
  11. 7.3.2 Europe Pain Management Drugs & Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pain Management Drugs & Devices Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pain Management Drugs & Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pain Management Drugs & Devices Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pain Management Drugs & Devices Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Pain Management Drugs & Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Pain Management Drugs & Devices Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Pain Management Drugs & Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Pain Management Drugs & Devices Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Medtronic Inc.
  14. 8.3.1 Medtronic Inc. Company Information
  15. 8.3.2 Medtronic Inc. Business Overview
  16. 8.3.3 Medtronic Inc. Pain Management Drugs & Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Medtronic Inc. Pain Management Drugs & Devices Product Portfolio
  18. 8.3.5 Medtronic Inc. Recent Developments
  19. 8.4 Eli Lilly & Co.
  20. 8.4.1 Eli Lilly & Co. Company Information
  21. 8.4.2 Eli Lilly & Co. Business Overview
  22. 8.4.3 Eli Lilly & Co. Pain Management Drugs & Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Eli Lilly & Co. Pain Management Drugs & Devices Product Portfolio
  24. 8.4.5 Eli Lilly & Co. Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Pain Management Drugs & Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Pain Management Drugs & Devices Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Abbvie Inc.
  32. 8.6.1 Abbvie Inc. Company Information
  33. 8.6.2 Abbvie Inc. Business Overview
  34. 8.6.3 Abbvie Inc. Pain Management Drugs & Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Abbvie Inc. Pain Management Drugs & Devices Product Portfolio
  36. 8.6.5 Abbvie Inc. Recent Developments
  37. 8.7 Purdue Pharmaceuticals Lp
  38. 8.7.1 Purdue Pharmaceuticals Lp Company Information
  39. 8.7.2 Purdue Pharmaceuticals Lp Business Overview
  40. 8.7.3 Purdue Pharmaceuticals Lp Pain Management Drugs & Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Purdue Pharmaceuticals Lp Pain Management Drugs & Devices Product Portfolio
  42. 8.7.5 Purdue Pharmaceuticals Lp Recent Developments
  43. 8.8 Novartis International Ag
  44. 8.8.1 Novartis International Ag Company Information
  45. 8.8.2 Novartis International Ag Business Overview
  46. 8.8.3 Novartis International Ag Pain Management Drugs & Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Novartis International Ag Pain Management Drugs & Devices Product Portfolio
  48. 8.8.5 Novartis International Ag Recent Developments
  49. 8.9 Hisamitsu Pharmaceutical Co. Inc.
  50. 8.9.1 Hisamitsu Pharmaceutical Co. Inc. Company Information
  51. 8.9.2 Hisamitsu Pharmaceutical Co. Inc. Business Overview
  52. 8.9.3 Hisamitsu Pharmaceutical Co. Inc. Pain Management Drugs & Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Hisamitsu Pharmaceutical Co. Inc. Pain Management Drugs & Devices Product Portfolio
  54. 8.9.5 Hisamitsu Pharmaceutical Co. Inc. Recent Developments
  55. 8.10 Glaxosmithkline
  56. 8.10.1 Glaxosmithkline Company Information
  57. 8.10.2 Glaxosmithkline Business Overview
  58. 8.10.3 Glaxosmithkline Pain Management Drugs & Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Glaxosmithkline Pain Management Drugs & Devices Product Portfolio
  60. 8.10.5 Glaxosmithkline Recent Developments
  61. 8.11 Endo International
  62. 8.11.1 Endo International Company Information
  63. 8.11.2 Endo International Business Overview
  64. 8.11.3 Endo International Pain Management Drugs & Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Endo International Pain Management Drugs & Devices Product Portfolio
  66. 8.11.5 Endo International Recent Developments
  67. 8.12 Djo Global Inc.
  68. 8.12.1 Djo Global Inc. Company Information
  69. 8.12.2 Djo Global Inc. Business Overview
  70. 8.12.3 Djo Global Inc. Pain Management Drugs & Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Djo Global Inc. Pain Management Drugs & Devices Product Portfolio
  72. 8.12.5 Djo Global Inc. Recent Developments
  73. 8.13 Astrazeneca Depomed Inc.
  74. 8.13.1 Astrazeneca Depomed Inc. Company Information
  75. 8.13.2 Astrazeneca Depomed Inc. Business Overview
  76. 8.13.3 Astrazeneca Depomed Inc. Pain Management Drugs & Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Astrazeneca Depomed Inc. Pain Management Drugs & Devices Product Portfolio
  78. 8.13.5 Astrazeneca Depomed Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pain Management Drugs & Devices Value Chain Analysis
  2. 9.1.1 Pain Management Drugs & Devices Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pain Management Drugs & Devices Production Mode & Process
  6. 9.2 Pain Management Drugs & Devices Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pain Management Drugs & Devices Distributors
  9. 9.2.3 Pain Management Drugs & Devices Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst